These 6 were subsequently included for meta-analysis. From those patients, 203 received prophylaxis and 194 were included in the control group. No significant reduction in the infection of pancreatic necrosis was observed. Absolute risk reduction ARR was 0.055 95% CI -0,084 to 0.194 and the mortality rate was RAR 0058 95% CI -0,194 to 0.154.
De esos pacientes, 203 recibieron profilaxis y 194 fueron incluidos en el grupo control no observándose reducción significativa de la infección de la necrosis pancreática, reducción absoluta del riesgo RAR de 0,055 95% IC -0,084 a 0,194 ni de la mortalidad, RAR 0,058 95% IC -0,194 a 0,154.